Contents

Search


secondary hyperparathyroidism

Etiology: - renal failure (hypocalcemia secondary to phosphorus retention) - inadequate calcium intake - steatorrhea - vitamin D deficiency or resistance Pathology: - reduced number of nephrons in chronic renal failure leads to hyperphosphatemia - increased secretion of FGF-23 from bone osteocytes & osteoblasts increases urinary phosphate secretion to maintain normal plasma phosphate levels - FGF-23 also suppresses renal 25-hydroxyvitamin D(3) 1-alpha-hydroxylase reducing calcitriol - reduced calcitriol results in diminished calcium absorption from the intestine & hypocalcemia - hypocalcemia stimulates PTH release resulting in release of calcium & phosphate from bone to normalize plasma calcium - PTH also increases excretion of phosphate by reducing resorption of phosphate from renal tubules - as renal function declines, increases in plasma FGF-23 & plasma PTH cannot normalize plasma phosphate & hyperphosphatemia occurs - elevated plasma phosphate further stimulates PTH release - ectopic calcification of calcium phosphate may worsen hypocalcemia Laboratory: - serum parathyroid hormone; hyperparathyroidism - serum 25-hydroxyvitamin D - consider 1,25-dihydroxyvitamin D in serum in patients with severe renal impairment & normal 25-hydroxyvitamin D levels - serum calcium: hypercalcemia - serum phosphorus Management: - treat hyperphosphatemia in patients with chronic renal failure (1st line) [2] - sevelamer rather than calcium carbonate [2] - normalize serum calcium & serum phosphorus to eliminate stimulus for PTH secretion [1] - correct vitamin D deficiency - calcitriol for patients with severe chronic renal failure regardless of serum 25-hydroxyvitamin D* * patients with severe chronic renal failure may be deficient in 25-hydroxyvitamin D-1-alpha hydroxylase * calcitriol suppresses PTH production by the parathyroid gland [1] * ref [1] does not consider measuring 1,25-dihydroxyvitamin D in serum * ref [2] argues against use of calcitriol in the setting of hypocalcemia because it may increase serum phosphate

General

hyperparathyroidism

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.
  2. NEJM Knowledge+ Nephrology/Urology